From DCAT Value Chain Insights (VCI)
Biogen has appointed Anabella Villalobos, PhD, as senior vice president of Biotherapeutic & Medicinal Sciences (BTMS). She will report to Michael Ehlers, MD, PhD, executive vice president and head of research and development.
Dr. Villalobos joins Biogen from Pfizer, where she most recently served as vice president and head of medicinal synthesis technologies. She has more than 25 years of industry experience in the areas of neuroscience and medicinal chemistry, including developing clinical candidates for Alzheimer’s disease, Parkinson’s disease, schizophrenia, and pain.
Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT).
Learn more and sign up to receive a complimentary subscription